Vasopressin regulation of maternal body fluid balance in pregnancy and lactation: A role for TRPV channels?


Journal

Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844

Informations de publication

Date de publication:
01 12 2022
Historique:
received: 26 01 2022
revised: 16 06 2022
accepted: 22 08 2022
pubmed: 30 8 2022
medline: 25 10 2022
entrez: 29 8 2022
Statut: ppublish

Résumé

Renal water reabsorption increases in pregnancy and lactation to expand maternal blood volume to cope with the cardiovascular demands of the developing fetus and new-born baby. Vasopressin (antidiuretic hormone) promotes renal water reabsorption and its secretion is principally stimulated by body fluid osmolality. Hence, lowered osmolality normally decreases vasopressin secretion. However, despite water retention profoundly reducing osmolality in pregnancy and lactation, vasopressin levels are maintained to drive blood volume expansion. Despite its importance for successful reproduction, the cellular mechanisms that maintain vasopressin secretion in the face of decreased osmolality during pregnancy and lactation are unknown. Vasopressin is secreted by neurons that are intrinsically osmosensitive through expression of N-terminal truncated-transient receptor potential vanilloid-1 channel, ΔN-TRPV1, which is mechanically activated by osmotically-induced cell shrinkage to increase vasopressin neuron activity. Vasopressin neurons also express TRPV4 but the role of TRPV4 in vasopressin neuron function is not well characterised. Here, we summarise our novel evidence showing that TRPV4 forms functional channels with ΔN-TRPV1 that have a greater single-channel conductance compared to channels with ΔN-TRPV1 alone. We propose that upregulation of TRPV4 heteromerisation with ΔN-TRPV1 might maintain vasopressin secretion in pregnancy and lactation to expand blood volume for successful reproduction.

Identifiants

pubmed: 36038076
pii: S0303-7207(22)00212-X
doi: 10.1016/j.mce.2022.111764
pii:
doi:

Substances chimiques

TRPV Cation Channels 0
Vasopressins 11000-17-2
Water 059QF0KO0R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111764

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Emily F Brown (EF)

Brain Health Research Centre, University of Otago, Dunedin, Aotearoa New Zealand; Centre for Neuroendocrinology, University of Otago, Dunedin, Aotearoa New Zealand; HeartOtago, University of Otago, Dunedin, Aotearoa New Zealand; Department of Physiology, University of Otago, Dunedin, Aotearoa New Zealand. Electronic address: emily.brown@otago.ac.nz.

Martin Fronius (M)

HeartOtago, University of Otago, Dunedin, Aotearoa New Zealand; Department of Physiology, University of Otago, Dunedin, Aotearoa New Zealand. Electronic address: martin.fronius@otago.ac.nz.

Colin H Brown (CH)

Brain Health Research Centre, University of Otago, Dunedin, Aotearoa New Zealand; Centre for Neuroendocrinology, University of Otago, Dunedin, Aotearoa New Zealand; HeartOtago, University of Otago, Dunedin, Aotearoa New Zealand; Department of Physiology, University of Otago, Dunedin, Aotearoa New Zealand. Electronic address: colin.brown@otago.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH